Therapeutics News and Research

RSS
Simvastatin may help sufferers with Alzheimer's

Simvastatin may help sufferers with Alzheimer's

Nanoparticles found near plaque-filled arteries

Nanoparticles found near plaque-filled arteries

New hope for diabetic retinopathy sufferers

New hope for diabetic retinopathy sufferers

High workloads for pharmacists increase the potential for medication errors

High workloads for pharmacists increase the potential for medication errors

Muscle restoration in an animal model of Duchenne muscular dystrophy

Muscle restoration in an animal model of Duchenne muscular dystrophy

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

Agile Therapeutics to report on new generation of transdermal contraceptives

Agile Therapeutics to report on new generation of transdermal contraceptives

New drug offers hope to muscular dystrophy and cystic fibrosis sufferers

New drug offers hope to muscular dystrophy and cystic fibrosis sufferers

Researchers finds meth receptor that could lead to therapy

Researchers finds meth receptor that could lead to therapy

New discoveries about stem cells in leukemia, breast and colon cancer

New discoveries about stem cells in leukemia, breast and colon cancer

Factors that dictate risk of developing primary or secondary cancer

Factors that dictate risk of developing primary or secondary cancer

Lexicon Reports on anti-angiogenesis target discoveries

Lexicon Reports on anti-angiogenesis target discoveries

More effective therapies for individual cancers  - personalized medicine

More effective therapies for individual cancers - personalized medicine

Cell Therapeutics settles law suit with Government

Cell Therapeutics settles law suit with Government

Selenium as therapy for prostate cancer

Selenium as therapy for prostate cancer

AccessPharmacy helps meet demands of pharmacy education

AccessPharmacy helps meet demands of pharmacy education

Expression Genetics completes phase I trial of lead drug candidate, EGEN-001

Expression Genetics completes phase I trial of lead drug candidate, EGEN-001

Cytochroma and Genzyme settle lawsuit

Cytochroma and Genzyme settle lawsuit

Cetuximab improves survival and slows progression of colorectal cancer

Cetuximab improves survival and slows progression of colorectal cancer

Snake venom toxin as a treatment for prostate cancer

Snake venom toxin as a treatment for prostate cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.